Non-Pharmacological Cognitive Health: The StrongerMemory Approach | Rob Liebreich - CEO, Goodwin Living

Episode notes

Send us Fan Mail Today on Progress, Potential And Possibilities, we explore a different kind of breakthrough in cognitive health - not a drug, not a device, but a simple daily practice that’s quietly transforming lives. Our guest is Rob Liebreich, President and CEO of Goodwin Living ( ), an organization serving thousands of older adults across the Washington, D.C. region. Rob has spent more than two decades at the forefront of senior living and aging services - leading large-scale communities, building platforms to improve how families navigate care decisions, and working to fundamentally shift the narrative around aging from one of decline to one of purpose and possibility. But this story isn’t just professional - it’s deeply personal. When Rob’s mother began experiencing cognitive decline, he refused to accept that deterioration was inevitable. Drawing on both his industry experience and a willingness to experiment, he developed a simple daily regimen - reading aloud, handwriting, and doing math - that helped her regain engagement, confidence, and independence.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• When High Performers Break: The Science of Staying SteadyTeamwork - A Better Way · on Neuroplasticity85 / 100
• "I Learn, Therefore I Evolve": Rethinking Human Learning in the Age of AI (ft. Dr. Barbara Oakley)2050 Investors · on Neuroplasticity78 / 100
• Aneesh Raman: AI won't decide the future of work - unless you let itWorkLab · on Neuroplasticity77 / 100
• S:8 E:2: Neuroplastic AI modelsIoT Unplugged · on Neuroplasticity75 / 100
• Psychedelics Might Be the Future of Mental Health | Althea CEO, Niko SkievaskiBoundary Breakers · on Neuroplasticity73 / 100
• How Revenue Marketing Makes the CMO a Business Growth DriverThe B2B Revenue Executive Experience · on Neuroplasticity71 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen